The ‘long-term’ effects of universal school-based anxiety prevention trials:A systematic review by Waldron, Samuel M. et al.
        
Citation for published version:
Waldron, SM, Stallard, P, Grist, R & Hamilton-Giachritsis, C 2018, 'The ‘long-term’ effects of universal school-
based anxiety prevention trials: A systematic review', Mental Health & Prevention, vol. 11, pp. 8-15.
https://doi.org/10.1016/j.mhp.2018.04.003
DOI:
10.1016/j.mhp.2018.04.003
Publication date:
2018
Document Version
Peer reviewed version
Link to publication
Publisher Rights
CC BY-NC-ND
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 22. May. 2019
 1 
 
 
The ‘Long-Term’ Effects of Universal School-based Anxiety 
Prevention Trials: A Systematic Review 
 
 
 
S. Waldron, P. Stallard, R. Grist and C. Hamilton-Giachritsis 
 
Final pre-print version.  
 
 
Waldron, S., Stallard, P., Grist, R., & Hamilton-Giachritsis, C. (2018). The ‘long-term’ effects 
of universal school-based anxiety prevention trials: A systematic review. Mental Health and 
Prevention, 11, 8-15.  
https://doi.org/10.1016/j.mhp.2018.04.003 
 
 
 
⁎ Corresponding author. E-mail addresses: samuel.waldron@bath.edu (S.M. Waldron), 
p.stallard@bath.ac.uk (P. Stallard), r.grist@bath.ac.uk (R. Grist), c.hamilton-
giachritis@bath.ac.uk (C. Hamilton-Giachritsis). 
Mental Health & Prevention 11 (2018) 8–15 
Available online 24 April 2018 2212-6570/ © 2018 Elsevier GmbH. All rights 
reserved. 
  
 2 
Abstract 
Objective: Debate is ongoing as to whether schools should routinely be running universally-
delivered anxiety prevention programs. Previous reviews have demonstrated positive short-
term effects, but none have provided a clear evaluation of the longer-term effects. This review 
focusses exclusively on randomized controlled trials (RCTs) of universal school-based 
anxiety prevention programs that include follow-up data of 12-months or beyond.  
Method: In total, 359 references from previous reviews in the field were screened, and 
PubMed and PsychInfo were also systematically searched. Eight studies met criteria (each 
based on cognitive-behavioural principles) comprising 7522 children aged nine-18 years. The 
raw data needed to calculate standardised effect size estimates was only available for three 
studies, and risk of bias was deemed high in most studies, thus a formal meta-analysis was 
not conducted.  
Results: Three of the eight studies reported greater reductions in anxiety symptomology in the 
prevention group compared to the control group at post-intervention (immediate effect), and 
each of these studies also reported maintenance of this effect at the 12-month follow-up. Two 
further studies reported a ‘delayed’ effect seen at the 12-month follow-up (but not at post-
intervention). Each of these five studies was evaluating the FRIENDS program, and 
estimated effect sizes at the 12-month follow-up varied from 0.2 to 0.69 (Hedges g). The final 
three studies (evaluating the E-COUCH and Aussie Optimism Program) reported no 
immediate or long-term effects.  
Conclusions: The findings from this review suggest that the effects of some universally 
delivered school-based anxiety prevention trials can last up to 12-months, but this may 
depend on various factors (including program-type). It was not possible to draw conclusions 
regarding the influence of delivery mode (teacher versus health professional), parent sessions 
or child booster sessions. Further high quality RCTs with long-term follow-up data are 
needed.  
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1. Introduction 
Anxiety disorders often start in childhood or adolescence (Costello, Egger, & Angold, 
2005), and can lead to significant distress, poor educational outcomes and comorbid mental 
and physical health problems (Donovan & Spence, 2000). Studies estimate childhood 
prevalence rates of between 10-15% (Snyder et al., 2009) and lifetime prevalence rates close 
to 30% (Kessler et al., 2005). Psychological interventions are available, with average 
treatment effect sizes (d) in the moderate region of 0.6 (Reynolds, Wilson, Austin, & Hooper, 
2012). However, cross-sectional research suggests that at any given time, as few as 18% of 
the children and adolescents that would meet criteria for an anxiety disorder are accessing 
mental health services (Essau, 2005). In response to this public health priority, there has been 
a proliferation of studies published since the turn of the century evaluating psychological 
programs designed to prevent the development of anxiety disorders in childhood and 
adolescence (Ahlen, Lenhard, & Ghaderi, 2015).  
Most anxiety prevention programs utilise cognitive behavioural theory, focussing on 
emotional and cognitive awareness, positive self-talk/imagery, attentional training, psycho-
education, relaxation, problem solving, exposure, behavioural experiments and cognitive 
restructuring (Stallard, 2010). Theoretically, it is argued that promoting protective/resilience 
factors such as individual coping skills can help counteract risk factors such as behavioural 
inhibition, parental anxiety and stressful life events (Donavan & Spence, 2000). Young 
people who have experienced anxiety prevention programs of this nature are thought to be 
less likely to develop anxiety problems in response to stressful life events due to the 
deployment of adaptive coping strategies (Barrett & Turner, 2001). 
Schools are well placed to host such programs because they have access to large 
numbers of young people, many of which will be at risk of developing anxiety disorders 
(Barrett & Pahl, 2006). Programs can be rolled out ‘universally’ to all pupils, ‘selectively’ to 
those pupils deemed at higher risk, and also to pupils ‘indicated’ as having elevated sub-
threshold symptoms (Haggerty & Mrazek, 1994). Although some evidence suggests that 
selective or indicated programs yeild better results for the prevention of depression (Merry et 
al., 2011), a recent large-scale meta-analytic review conducted by Werner-Seidler, Perry, 
Calaer, Newby and Christensen (2017) reported similar effect sizes for universal and 
selective/indicated school-based anxiety prevention programs. Universal programs can be 
expensive and time-consuming to set up, but they are also perceived as less stigmatizing 
(Fisak, Richard, & Mann, 2011), can overcome difficulties associated with screening for risk 
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(Donovan & Spence, 2000) and can reach all children regardless of symptomology (Masia-
Warner, Nangle, & Hansen, 2006). Recruitment, transport and drop-out rates are less of an 
issue when running universal programs to all pupils in a school, and universal programs can 
be weaved into the school curriculm teaching skills that will be useful to all participants, not 
just those with sub-clinical symptoms (Barrett & Pahl, 2006). 
Debate is ongoing as to whether schools should routinely be running universally-
delivered anxiety prevention programs, and the existing reviews in this area have yet to 
provide clear data regarding the ‘long-term’ effects. For example, although Werner et al. 
(2017) suggest that small (0.13) effect sizes were evident for anxiety prevention programs at 
12-months follow-up, this represents combined data aggregated across universal, selective 
and indicated trials. Several broad-ranging reviews already exist that are fully inclusive of 
indicated, selective and universal programs, but few focus in suffcient detail on the long-term 
effects of universal school-based anxiety prevention programs. For example, Neil and 
Christensen (2009) reviewed the effectiveness of universal, selective and indicated school-
based anxiety prevention programs, and of the 16 universal trials inlcluded in their review, 11 
reported positive post-intervention effects (with effect sizes ranging from 0.31-1.37). Three 
of these trials reported a long-term effect at 12-months, but most trials were limited to short-
term follow-up only. Therefore little can be concluded from these reviews regarding the long-
term effectiveness of universally delivered school-based anxiety prevention programs.  
Stockings et al. (2016) recently conducted a meta-analysis of 146 anxiety and 
depression prevention trials, and small meta-effects for the 24 universal anxiety prevention 
trials were identified at post-intervention (0.16) through to 6-9 months follow-up (0.13). 
However, it is not possible to partial out the results from school and community-based trials. 
Teubert and Pinquart (2011) conducted a meta-analysis of 65 anxiety prevention studies, 
reporting small meta effect size estimates of 0.22 at post-intervention and 0.19 at short-term 
follow-up. However, these data are aggregated across universal, selective and indicated trials, 
are not confined to school-based studies, and do not include longer-term follow up data. The 
reviews conducted by Fisak et al. (2011) and Ahlen et al. (2015) have similar limitations.  In 
summary, although previous reviews suggest that the general effects of different types of 
anxiety prevention programs may last up to six-nine months (e.g., Stockings et al., 2016; 
Werner-Seidler et al., 2017), these reviews do not provide specific details about the long-term 
effects of universally delivered school-based programs.  
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Therefore this review focuses exclusively on universally delivered school based 
anxiety prevention trials that have follow-up data of at least 12-months (and beyond). This 
will provide public policy and education colleagues with useful information regarding true 
duration effects and how regularly ‘booster’ sessions might be needed. This focus is 
important because some authors have argued that the benefits of prevention programs may 
not be seen until the recipients have had the opportunity to pass through a period of ‘elevated 
risk’ (Gillham, Shatté, & Reivich, 2001). An analysis of how many studies reported ‘delayed’ 
effects (i.e., effects that do not emerge until several months after the prevention program 
finishes) will provide an estimate as to the extent to which previous reviews focusing only on 
short-term ‘prevention’ effects may have missed potential longer-term benefits.  
An a-priori decision was taken to focus on randomised controlled trials (RCTs) in the 
current review, because public health colleagues are looking for high quality evidence using 
‘gold standard’ methodology. A decision was also taken to focus on programs including 
direct work with the pupils, because this is often the main approach available to schools. It is 
acknowledged that by focussing on RCTs of programs that emphsise direct work with 
children/adolescents, this review is likley to capture mostly (if not entirely) cognitive-
behavioural prevention programs. 
Based upon the tentative conclusions drawn by previous reviews in the field, it was 
hypothesised that a small effect size estimate will be found at the 12-month follow-up for the 
majority of studies included in this review. No specific predictions were made regarding the 
influence of delivery mode (teacher versus health professional), parent sessions or child 
booster sessions, or whether differential results will be observed according to gender and age, 
but these factors will be explored. Because several of the large-scale reviews already 
published in this area have captured a wide scope of studies, this review will inspect the 
references cited by these reviews first before conducting a new database search to check for 
other studies not already captured.  
 
2. Method 
2.1. Inclusion Criteria 
In order to focus this review on the long-term effects of universal school-based 
anxiety prevention trials, the following inclusion criteria were developed:  
 To be included in this review the study design must have been a randomised 
controlled trial (RCT) 
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 Population: children and adolescents aged 5-18 years at the beginning of the trial; the 
setting must have been in school (during normal school hours) 
 Intervention: a universal program offered to all pupils in the class/school/year group 
citing anxiety as a primary or dual prevention target (with a clear theoretical 
rationale); some direct work must have been undertaken with the children as part of 
the program 
 Comparison group: either a wait-list control, attention-control or no intervention 
control 
 Outcome measures: standardised child-completed self-report questionnaires of 
anxiety symptomology (taken pre, post and a minimum of 12-months following 
intervention).  
 Only peer-reviewed journal articles published in the English language between 1980 
and January 2017 were considered.    
 
2.2. Search Protocol 
Step one was to screen all 359 publications identified by the six key reviews noted in 
the introduction against the inclusion criteria (Ahlen et al., 2015; Fisak et al., 2011; Neil & 
Christensen, 2009; Stockings et al., 2016; Teubert & Pinquart, 2011; Werner-Seidler et al., 
2017). Removing duplicates revealed 178 different publications. Of these, 147 were excluded 
based on title or abstract alone. For the remaining 31 publications, the full text was accessed 
because it was not possible to assess eligibility based on title and abstract alone. The 
PRISMA flow-chart illustrated in Figure 1.1 provides an overview of this process. The first 
author (SW) and research assistant (RG) conducted this process separately and reached the 
same conclusion for 97% of the 178 separate publications (yielding a Cohen’s Kappa of .75). 
Following inter-rater discussion to resolve five discrepancies, 11 publications were judged 
eligible for the current review.  
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Figure 1.1. PRISMA flow-chart depicting step one of the search protocol 
 
In order to check whether any additional studies could be identified via a new 
systematic search, step two involved carrying out database searches on PsychNet and 
PubMed and screening all identified publications against the same inclusion criteria. The 
PsycNet terms developed in collaboration with a process expert were: ‘school OR universal 
OR adolescent OR child OR children OR youth OR teen OR teenager’ AND ‘prevention OR 
preventative’ AND ‘anxiety OR anxious’. The PubMed terms developed in collaboration 
with a process expert were: “school” OR “universal” OR “adolescent” OR “child” OR 
“children” OR “youth” OR “teen” OR “teenager” AND “prevention” OR “preventative” 
AND “anxiety” OR “anxious”. The searches were performed at the ‘title and abstract’ level. 
The PsychNet search yielded 943 publications and the PubMed search yielded 1023 
publications. SW and RG screened all publications separately and excluded the vast majority 
of publications based on abstract/title alone, or because the study had already been screened 
in step one of the search protocol. SW and RG accessed a total of eight previously 
unscreened full-text articles. After discussion, only one of these was deemed to meet the 
inclusion criteria for the current review. This study had not been picked up by the previous 
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broad-ranging reviews in this area because it was published after their searches had taken 
place.  
 
2.3. Data Extraction 
For the purpose of this review, linked publications drawing on the same participants 
were collapsed yielding eight ‘studies’ in total. For each of these studies, the information and 
data were extracted by SW and checked by RG. Any differences were resolved by discussion 
and re-examination of the full text article.  
 
2.4. Risk of Bias 
The Cochrane Collaboration ‘Risk of Bias’ tool (Higgins & Green, 2011) was used to 
assess the quality of each of the eight studies included in the current review. SW and RG 
independently allocated a code of Low Risk, High Risk or Unsure (when insufficient 
information was provided by the published article to make a judgment) to each of the 
following categories: allocation sequence generation; sequence concealment; reporting of 
incomplete data; selective reporting of data; blinding of participants and personnel; blinding 
of outcome assessment; and other possible risks of bias. Overall, 77% of SW and RG’s 56 
code allocations were identical, yielding a Cohen’s Kappa of .64. Each of the 13 
discrepancies was resolved via discussion and re-examination of the full-text article. Where 
SW and RG agreed that insufficient information was provided by the published article to 
make a risk of bias judgment for a particular category, a clarification request was emailed to 
the corresponding author. Seven of the eight corresponding authors were contacted in this 
way and two responded with the information requested. In all other instances, a score of two 
(representing the category ‘unsure’) was retained for the risk of bias rating. 
 
2.5. Effect Size Calculations 
In order to compare the outcome data of the studies included in this review, 
standardized effect size estimates (ES) were calculated for each study (where possible), 
representing the difference between the prevention and control group anxiety symptomology 
at each time point. Cohen’s d (Cohen, 1988) was calculated first by subtracting the mean 
prevention group score from the mean control group score and dividing by the pooled 
standard deviation. These statistics were then transformed into Hedges’ g (Hedges, 1981) to 
ensure unbiased conservative estimates with an adjustment for small sample sizes. Positive 
ES estimates indicate that the intervention group improved more than the control group on a 
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given measure. An ES of .20 is generally considered small, whereas an ES of .50 is 
considered moderate and an ES of .80 is considered large (Cohen, 1988). Only three of the 
eight studies included in this review (38%) published the data needed to calculate these effect 
sizes. Raw mean, standard deviation and sample size data were requested from the 
corresponding authors of the other five studies, but none was returned. 
 
3. Results 
The results section first describes key study characteristics (including quality), before 
reviewing anxiety prevention data and concluding with a brief summary of secondary 
outcome data. In terms of anxiety prevention data, the focus will be on symptomology rather 
than diagnosis, because comparable data were available across all studies. Key study details 
are summarised in Table 1.1.  
 
3.1. Study Characteristics and Quality 
All of the eight studies included in this review evaluated anxiety prevention programs 
based on cognitive-behavioural principles. Five of the eight studies (63%) evaluated the 
FRIENDS program, which was developed by Barrett, Lowry-Webster and Holmes (1999) 
and aims to teach children techniques in relaxation, cognitive restructuring, attentional 
training, parent-assisted exposure and peer support. Three of these studies were conducted in 
Australia by the program developers (Barrett, Lock, & Farrell, 2005; Lock & Barrett, 2003; 
Lowry-Webster, Barrett, & Lock, 2003), one was conducted in Germany (Essau, Conradt, 
Sasagawa, & Ollendick, 2012) and one was conducted in the UK (Stallard et al., 2014). Two 
of the other three studies evaluated the Aussie Optimism Program (AOP), which was 
developed by Rooney, Pike and Roberts (2000) and aims to teach children to identify and 
challenge negative thoughts and feelings about the self, current life circumstances and the 
future. Both of these trials were conducted in Australia by the developers (Roberts et al., 
2010; Rooney, Hassan, Kane, Roberts, & Nesa, 2013). The remaining study evaluated the E-
COUCH program, which was developed by Calear, Christensen, Griffiths and Mackinnon 
(2013) and aims to teach children cognitive behavioural techniques and relaxation. This trial 
was conducted in Australia by the program developers (Calear et al., 2016). Only the E-
COUCH program was delivered online. Teachers delivered the interventions in three of the 
studies (38%), health professionals delivered the interventions in another three of the studies 
and two of the studies compared teacher and health professional delivery. 
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The eight studies included in this review cover an age range of nine to 18 years 
(although the focus of most of the studies was on primary school aged children). Slightly 
more female than male participants were recruited into most of the studies. Sample sizes 
ranged from 496 to 1767 participants when the trial began, totalling 7522 children across all 
studies. In terms of fidelity, five of the eight studies (63%) assessed randomly chosen 
sessions, two studies relied upon facilitator ‘self-report’ and Calear et al. (2016) used 
computer activity logs because the program was delivered online. Six of the eight studies 
(75%) included a follow-up measure at 12-months, two included a follow-up measure at 18-
months, one included follow-up at both 24 and 36-months, and one included follow-ups at 
30, 42 and 54-months.  
Table 1.2 indicates that the eight studies included in this review generally suffer from 
high risk of bias. The studies conducted by Stallard et al. (2014) and Rooney et al. (2013) 
yielded the lowest risk of bias (both scoring 11/21), whereas the studies conducted by Barrett 
et al. (2005), Lock and Barrett (2003) and Lowry-Webster et al. (2003) each yielded the 
highest risk of bias scores (17/21). Attritions rates were generally less than 20%, with the 
exception of Essau et al. (2012) and Calear et al. (2016) where the attrition rates were 52% 
and 61% respectively (yielding reduced sample sizes of 309 and 687 respectively at the 12-
month follow-up). Only the two most recent studies included a clear power analysis (Calear 
et al., 2016; Stallard et al., 2014). None of the studies included in this review included an 
intervention control group.
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Table 1.1 
Overview of the Eight Studies Included in this Review 
 
Study 
Program & 
country 
Focus N 
Age & 
gender 
Delivery Sessions Hrs 
Key 
measures 
Control 
LT 
follow 
up(s) 
LT 
attrition 
Barrett et al. (2005) 
FRIENDS, 
Australia 
Anxiety 692 
9-10 & 14-16 
(51% male) 
Face-to-face 
(MHP) 
10 child, 2 
booster, 4 parent 
18 
SCAS 
CDI 
NI 12m 18% 
Calear et al. (2016) 
E-COUCH, 
Australia 
Anxiety 1767 
12-18 (31% 
male) 
Online        
(T v MHP 
guided) 
6 child 3.5 
SCAS-GAD 
SAS-A 
GAD-7 
CES-D 
WL 12m 61% 
Essau et al. (2012) 
FRIENDS, 
Germany 
Anxiety 638 
9-12 (54% 
male) 
Face-to-face 
(G) 
10 child, 2 
booster, 4 parent 
14 
SCAS 
RCADS 
WL 12m 52% 
Lock & Barrett (2003); 
Barrett et al. (2006)  
FRIENDS, 
Australia 
Anxiety 977 
9-10 & 14-16 
(50% male) 
Face-to-face 
(MHP) 
10 child, 2 
booster, 4 parent 
18 
SCAS 
RCMAS 
CDI 
 
WL 
12m 
24m 
36m 
13% 
Lowry- Webster et al. 
(2003) 
FRIENDS, 
Australia 
Anxiety 594 
10-13 (47% 
male) 
Face-to-face 
(T) 
10 child, 2 
booster, 3 parent 
15 
SCAS 
RCMAS 
CDI 
WL 12m 21% 
Roberts et al. (2010) 
AOP, 
Australia 
Anxiety & 
depression 
496 
11-13 (46% 
male) 
Face-to-face 
(T) 
20 child 20 
RCMAS 
CDI 
NI 18m 12% 
Rooney et al. 
(2013a,b); Johnstone et 
al. (2014) 
AOP, 
Australia 
Anxiety & 
depression 
910 
9-10 (51% 
male) 
Face-to-face 
(T) 
10 child 10 
SCAS 
CDI 
NI 
18m 
30m  
42m  
54m 
14% 
Stallard et al. (2014) 
FRIENDS, 
UK 
Anxiety 1448 
9-10        
(46% male) 
Face-to-face           
(T v MHP) 
9 child 9 
RCADS 
 
AC + NI 12m 8% 
Delivery: MHP = Mental Health Professional; T = Teacher; G = Graduate student. Measures: SCAS = Spence Children's Anxiety Scale; GAD = Generalized Anxiety Disorder; RCADS 
= Revised Children's manifest Anxiety Scale; CDI = Children's Depression Inventory; SASA = Social Anxiety Scale for Adolescents ; CESDS = Centre for Epidemiological Studies 
Depression Scale; RCMAS = Revised Children's Manifest Anxiety Scale. Control: WL = Wait-List Control; NI = No Intervention Control; AC = Active Control
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3.2. Long-term Anxiety Prevention Effects  
A formal meta-analysis was not conducted because of the relatively small number of 
studies included in this review and also the high risk of bias present in most of these studies. 
Table 1.3 provides an overview of the key anxiety prevention effects for each study1. Three of 
the eight studies included in this review reported greater reductions in anxiety symptomology 
in the prevention group compared to the control group at post-intervention (immediate effect) 
and each of these studies also reported maintenance of this effect at 12-months follow-up. 
Two studies reported limited or no immediate effect with a ‘delayed’ effect at 12-months 
follow-up. Estimated effect sizes at 12-months follow-up varied from 0.2 to 0.69 (Hedges g) 
and these effects were reported for the SCAS for four studies and the RCADS for one study. 
Only one of these studies reported an anxiety prevention effect beyond 12-months and this 
                                                 
1 The effect size estimates provided in parentheses are for the difference between the prevention and 
control group at each time point. Only three of the studies (38%) provided sufficient information to calculate 
relevant estimated effect sizes. 
Table 1.2  
Risk of Bias Summary 
Study A B  C  
 
D  E  F  G  Total                   
(min = 7, max =21) 
Barrett et al. (2005) 2 2 3 2 3 2 3 17 
Calear et al. (2016) 1 1 3 1 3 3 3 15 
Essau et al. (2012) 2 2 3 1 3 2 3 16 
Lock & Barrett 
(2003); Barrett et 
al. (2006) 
2 2 3 2 3 2 3 17 
Lowry- Webster et 
al. (2003) 
2 2 3 2 3 2 3 17 
Roberts et al. (2010) 2 2 3 2 3 1 3 16 
Rooney et al. 
(2013a,b); 
Johnstone et al. 
(2014) 
1 1 1 1 3 1 3 11 
Stallard et al. (2014) 1 1 1 1 3 1 3 11 
A = Random sequence generation; B = Allocation concealment;  C = Incomplete outcome 
Data; D = Selective reporting; E = Blinding of participants and personnel; F = Blinding of outcome 
assessment; G = Other sources of bias; 1 = low risk; 2 = unclear; 3 = high risk 
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was limited to the younger of the two age groups recruited. The other three studies reported 
no post-intervention or longer-term effects. 
Although it was not possible to conduct a meta-analysis analysis of whether 
prevention outcomes were associated with particular study characteristics, it is worth noting 
that each of the five studies that reported a prevention effect at 12-months was evaluating the 
FRIENDS program (two of these studies were conducted outside of Australia by researchers 
not involved in the development of the program). However, an important caveat is that four 
of these studies were deemed to have high risk of bias (scores of 16 or 17/21). Each of the 
five studies reporting anxiety prevention effects at 12-months provided approximately ten 
child sessions, but it is worth noting that Stallard et al. (2014) reported prevention effects 
(albeit with a small effect size) without the use of parent or child booster sessions. Essau et 
al. (2012) explored parental attendance at allocated sessions and reported that this did not 
influence anxiety prevention data. 
Long-term prevention effects were generally more likely to be reported by studies that 
evaluated delivery by health professionals/graduates than teachers and Stallard et al. (2014) 
found significant long-term prevention effects only when delivered by health professionals 
(not teachers). However, one study (Lowrey-Webster et al., 2003) did report 12-month 
prevention effects using teacher delivery. In terms of the total number of intervention hours 
provided, the studies reporting long-term prevention effects ranged from nine to 18 hours, 
with slightly larger effect sizes reported by the studies providing more intervention hours. 
However, a high number of intervention hours was not sufficient to yield long-term 
prevention effects (cf. Roberts et al., 2010). Results did not differ according to sample size or 
control type. 
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N.S = non-significant effect; a = ES could not be calculated; IG = intervention group; CG = control 
group; MHP = mental health professional 
 
Three of the studies reporting 12-month anxiety prevention outcomes compared 
effects for different aged children. Barrett et al. (2005) and Lock and Barrett (2003) 
compared the effects for children aged 9-10 and 14-16. Although significant effects were 
Table 1.3 
Anxiety Prevention Outcomes ( available effect size estimates in parentheses) 
Study Summary Post-
intervention 
12m >12m 
Barrett et al. 
(2005) 
Only at 12m was a significant difference 
found between the IG and CG (for both 
age groups recruited).  
N.S Sig 
effecta 
- 
Calear et al. 
(2016) 
No significant differences were found 
between the CG and either the teacher-
led IG or the health professional-led IG 
at any time point. 
N.S N.S - 
Essau et al. 
(2012) 
Reductions in anxiety symptoms were 
significantly greater in the IG than the 
CG for all children at 12m (only for 
younger children at post-intervention) 
Sig effect for 
younger 
childrena 
Sig effect 
(.69) 
- 
Lock & Barrett 
(2003); Barrett 
et al. (2006) 
Reductions in anxiety symptoms were 
significantly greater in the IG than the 
CG at post-intervention and 12m for both 
age groups (maintained at 24m and 36m 
for the younger children only).  
Sig effecta Sig 
effecta 
Sig effect 
for 
younger 
children at 
24m & 
36m a 
 
Lowry- Webster 
et al. (2003) 
Reductions in anxiety symptoms were 
significantly greater in the IG than the 
CG at post-intervention and 12m. 
Sig effect 
(.45) 
Sig effect 
(.53) 
- 
Roberts et al. 
(2010) 
No significant differences found between 
the IG and the CG at any time point. 
N.S - N.S at 18m 
Rooney et al. 
(2013a,b); 
Johnstone et al. 
(2014) 
Same as above. N.S - N.S at 
18m, 30m, 
42m & 
54m 
 
Stallard et al. 
(2014) 
Reductions in anxiety symptoms were 
significantly greater in the health 
professional-led IG than the CG at 12m 
(not for the teacher-led IG).   
- Sig effect 
for MHP 
IG (.20) 
- 
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reported for all children, slightly greater reductions in anxiety were reported by both studies 
for the younger children at 12-month follow-up. Essau et al. (2012) reported a mixed picture 
with greater reductions in anxiety for the 9-10 year olds at post-intervention, but greater 
reductions in anxiety for the 11-12 year olds at 12-month follow-up. In terms of gender, one 
study (Lock & Barrett, 2003) reported that reductions in anxiety over time in the intervention 
group were greater for females than males. Another study (Barrett, Farrell, Ollendick, & 
Dadds, 2006) reported that longer-term anxiety prevention effects stopped by 36 months for 
females, but were maintained at 36 months for males.  
In terms of the three studies that failed to find immediate or long-term anxiety 
prevention effects, two of these were evaluating the Aussie Optimism Program (AOP) and 
one was evaluating the E-COUCH program. Given the small number of studies included in 
this review, it is difficult to offer explanations as to why these studies failed to report long-
term anxiety prevention effects. However, it is worth noting that in contrast to the FRIENDS 
program (where the focus is entirely on anxiety prevention), AOP has a dual focus on anxiety 
and depression prevention. Both of the AOP studies also evaluated delivery by teachers, 
whereas most of the FRIENDS studies evaluated delivery by external health professionals or 
graduates. E-COUCH is unique in the sense that it is the only program included in this review 
delivered online, and the total intervention hours provided by E-COUCH was also 
considerably lower than the other studies in this review.  
 
3.3. Long-term Secondary Prevention Effects 
Two of the five studies included in this review that reported long-term anxiety 
prevention effects also reported long-term secondary effects. Essau et al. (2012) and Lock 
and Barrett (2003) reported a significant prevention effect for depression at 12-months 
follow-up. Essau et al. (2012) also reported significant prevention effects for school-based 
performance and perfectionism at 12-months follow-up. However, three of the five studies 
included in this review that reported long-term anxiety prevention effects did not find 
evidence for long-term secondary prevention effects. None of the studies that failed to find a 
long-term anxiety prevention effect reported long-term secondary effects. Despite having a 
dual focus on depression-prevention, the two studies evaluating the AOP also failed to find 
effects on mood-related measures. 
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4. Discussion 
This systematic review is the first to focus exclusively on the longer-term 
effectiveness of universally delivered school-based anxiety prevention programs. Eight 
studies evaluating randomised controlled trials (RCT) with follow-up data of 12-months or 
beyond were identified, totalling 7522 children aged nine-eighteen years (although several of 
the studies focused on primary aged children). Each of these studies was evaluating a 
program based on cognitive-behavioural principles. Although this was not an eligibility 
requirement, no RCT studies evaluating programs based on other models (e.g., exercise, 
education alone) could be found that included follow-up periods of 12-months or beyond.  
The hypothesis that a small effect size would be found at the 12-month follow-up for 
the majority of studies included in this review was largely supported, with five out of the 
eight studies reporting significant anxiety prevention effects at the 12-month follow-up 
(Barrett et al., 2005; Essau et al., 2012; Lock & Barrett, 2003; Lowry-Webster et al, 2003; 
Stallard et al., 2014). Each of these studies reporting long-term prevention effects was 
evaluating the FRIENDS program, whilst the three studies that failed to find immediate or 
longer-term effects were evaluating the AOP and the E-COUCH programs (Calear et al., 
2016; Roberts et al., 2010; Rosanna Rooney et al., 2013). This suggests that the short and 
long-term effects may depend on various factors (including program-type).  
Our findings are broadly consistent with the general anxiety prevention literature, 
which has tended to demonstrate that programs do have small-moderate prevention effect 
sizes (Teubert & Pinquart, 2011) and can be delivered in schools (Barrett & Pahl, 2006). Our 
finding that not all programs evaluated led to positive prevention effects however, is not 
atypical either (Ahlen et al., 2015). The anxiety prevention literature has highlighted that 
program content and delivery is important and has typically demonstrated more support for 
the FRIENDS program than any other (Fisak et al., 2011), as was found in the current review. 
Specifically, the results from our review also extend the short-term effects of universal 
school-based anxiety prevention programs reported by Neil and Christensen (2009) and the 
tentative conclusions drawn by more recent reviews that the effects of universal anxiety 
prevention programs can sometimes last beyond six months (Stockings et al., 2016; Werner-
Seidler et al., 2017).  
It is hoped that this review will be useful for public health and education colleagues. 
Although some of the 12-month follow-up effect sizes are small (ranging from 0.20 to 0.69), 
such changes in the trajectory of anxiety symptomology in school-aged children could have 
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wide-ranging benefits if scaled up to population estimates (Nehmy & Wade, 2014). However, 
it is important to highlight that the current review found no reliable evidence suggesting that 
effects endure beyond 12-months. Thus, annual booster sessions are likely to be needed in 
order to maintain effects. It is also important to highlight that only two studies reported 
delayed effects at the 12-month follow-up that were not present at post-intervention. 
Therefore it is unlikely that previous reviews that have relied largely on studies with only 
short-term follow-up periods have been drastically underestimating the potential longer-term 
benefits of universal school-based anxiety prevention programs (Neil & Christensen, 2009). 
  The current review cannot draw firm conclusions regarding the influence of delivery 
mode or program content, but each of the five studies that reported long-term prevention 
effects was evaluating the FRIENDS program (Barrett et al., 1999). It is encouraging that two 
of these trials were conducted outside of Australia by researchers not involved in the 
development of the program. The results from one of these studies (Stallard et al., 2014) 
suggests that external delivery by health professionals may yield better outcomes than 
internal delivery by teachers. This study also reported 12-month prevention effects without 
the provision of parent sessions. Previous research is mixed regarding the additive benefit of 
involving parents in cognitive behavioural treatment (Breinholst, Esbjørn, Reinholdt-Dunne, 
& Stallard, 2012) and Essau et al. (2012) found that parent attendance at designated sessions 
did not impact upon anxiety prevention outcomes. Stallard et al. (2014) also reported a 12-
month prevention effect without child booster sessions, suggesting that adding these on a 
yearly basis may be sufficient. Further controlled research will be needed to compare 
different parent and child booster session options.  
Results from another study included in this review (Barrett et al., 2006) suggest that 
anxiety prevention effects may last longer in younger than older children. Indeed, a previous 
meta-analysis conducted by Tebert and Pinquart (2011) indicated that anxiety prevention 
programs are generally less effective for older adolescents. Nehmey and Wade (2014) suggest 
that programs like FRIENDS, which are largely targeted at primary school children, may 
need to be adapted for older secondary age children. The current review is not able to draw 
conclusions regarding the use of online computer technology as a delivery mode because 
only one study of this nature was included in this review (and reported no immediate or 
prevention effects).  
Finally, few explanations can be offered as to why three of the eight studies included 
in this review failed to find immediate or long-term anxiety prevention effects. However, this 
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review does raise the interesting question as to whether part of the reason the FRIENDS 
program yielded better results than the AOP program might be because FRIENDS has a 
primary focus on anxiety prevention whereas AOP has a dual focus on anxiety and depression 
prevention. Perhaps further research would benefit from testing whether anxiety-specific 
prevention programs yield better effects than dual-focus or trans-diagnostic programs. 
 
4.1. Limitations and Conclusions 
In summary, this review suggests that, in some circumstance at least, running the 
FRIENDS program universally in schools can yield positive long-term effects.. This is 
encouraging, and although effect sizes were small-moderate (ranging from 0.20 to 0.69), 
could have substantial societal benefits if scaled up to a population level (Nehmy & Wade, 
2014).  
However, the results of this review need to be taken with some caution due to a 
number of limitations. The first is the small number of studies that met eligibility criteria and 
also the high risk of bias apparent in most of these studies. Secondly, it is a significant 
limitation that a meta-analysis could not be conducted on the data, meaning few conclusions 
can be drawn regarding the influence of different factors (e.g., program content, delivery 
mode) on long-term anxiety prevention outcomes. Further high quality RCTs are needed to 
address the methodological and theoretical questions raised throughout this review. Indeed, 
future RCTs need to pay more attention to the criteria outlined by the Cochrane Collaboration 
‘Risk of Bias’ tool (Higgins & Green, 2011). In particular, allocation concealment, cluster 
randomisation and random sequence generation methods are needed, along with more 
detailed reporting of methods, data and analyses. Recent studies in this field have begun to 
reduce possible sources of bias and have published protocols in advance of the trial (Calear et 
al., 2016; Stallard et al., 2014), thus allowing for transparent inspection of the data and 
thorough assessment of study quality. 
It is also worth noting that the results of this review are a product of the inclusion 
criteria established. It is possible that different results may have been found if uncontrolled 
trials had been included, and this may have also resulted in the inclusion of studies evaluating 
programs based on non-cognitive behavioural models (such as exercise or education-alone). 
Further research may be needed to compare cognitive-behavioural programs with other 
approaches (see Stockings et al, 2016). It is also worth noting that the focus of this review 
was on anxiety symptomology data (rather than diagnosis), because comparable data were 
 19 
available across studies. Further larger-scale research will also need to consider the long-term 
impact of universal school-based anxiety prevention programs on diagnosis thresholds, which 
will help inform an economic evaluation. 
Finally, previous research also suggests that the FRIENDS program does not always 
have the desired effect when using it in different contexts, geographical locations and with 
varying populations (Miller et al., 2011). This review was not able to explore the potential 
barriers to running anxiety prevention programs in ‘real-life’ effectiveness conditions. For 
example, we do not know how effect sizes may have changed if the schools involved in the 
studies reviewed herein had begun integrating the anxiety prevention programs within their 
curriculums, and in different contexts without the support of researchers with a vested interest 
in fidelity and controlled conditions. Indeed, program effects typically reduce under the 
effectiveness conditions of ‘usual care’ (Marchand, Stice, Rohde & Becker, 2011). 
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